Fenethazine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H18N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8J97CUZ4HX, chemically known as 10h-phenothiazine-10-ethanamine, n,n-dimethyl-, monohydrochloride but generally known as fenethazine, which bears US NIH Compound Identifier 68223. European Medicines Agency schedules Fenethazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07558MIG. The term FENETHAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). FENETHAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenethazine under HS 29343090 and SITC 51578. As of Q4 2014, FENETHAZINE remains the US FDA Preferred Term for this commodity. Fenethazine bears US NLM identifiers UMLS ID C0060166 and NCI Concept Code C65646. SMILES: S1C2C(N(CCN(C)C)C3C1CCCC3)CCCC2.